Apolipoprotein E gene polymorphism in cerebrovascular disease: A case-control study

Clinical Genetics

Volumn 62, Issue 1, 2002, Pages 39-44

  Luthra, K ^a   Prasad, K ^a   Kumar, P ^a   Dwivedi, M ^a   Pandey, R M ^a   Das, Nibhriti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apolipoprotein E; Asian Indians; Genotyping; PCR RFLP; Polymorphism; Stroke

Indexed keywords

APOLIPOPROTEIN E; TRIACYLGLYCEROL;

ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; INDIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0036665058     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620105.x     Document Type: Article

References (37)

1. Tanaka H, Yokayama T. Cerebrovascular disease. In: Detels R, Holland WW, eds. Oxford textbook of public health, 3rd edn. Oxford: Oxford University Press, 1997: 1065-1079.
2. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas AM, Thorvaldsen P, Tuomilehto J. Stroke incidence and mortality correlated to stroke risk actors in the WHO MONICA Project. An ecological study of 18 populations. Stroke 1997: 28: 1367-1374.
3. Kanter MC, Sherman DG. Strategies for preventing stroke. Curr Opin Neurol Neurosurg 1993: 6(1): 60-65.
4. Khaw KT. Epidemiology of sroke. J Neurol Neurosurg Psychiatry 1996: 61: 333-338.
5. Gill JS, Zezulka AV, Shipley MJ, Gill SK, Beevers DG. Stroke and alcohol consumption. N Eng J Med 1986: 315: 1041-1046.
6. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six year mortality from stroke in 350 977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989: 320: 904-910.
7. Ueshima H, Iida M, Shimamoto T et al. Multivariate analysis of risk factors for stroke: eight year study of farming villages in Akita. Japan Prev Med: 1980: 9: 722-740.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988: 8: 1-21.
9. Weisgraber KH, Apolipoprotein E. structure-function relationships. Adv Protein Chem 1994: 45: 249-302.
10. Skene JHP, Shooter EM. Denervated sheath cells secrete a new protein after nerve injury. Proc Natl Acad Sci USA 1983: 80: 4169-4173.
11. Stoll G, Muller H, Trapp B, Griffin J. Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia 1989: 2: 170-176.
12. Hixson JE for the Pathobiological Determinants of Atherosclerosis Youth (PDAY) research group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Throm Vasc Biol 1991: 11: 1237-1244.
13. Cattin L, Fisicaro M, Tonizzo M et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arteriosler Throm Vasc Biol 1997: 17: 91-94.
14. Utermann G, Hradewig A, Zimmer F. Apo E phenotypes in patients with myocardial infarction. Human Genet 1984: 65: 237-241.
15. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995: 91: 265-269.
16. Margaglione M, Seripa D, Gravina C et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke. An Italian case-control study. Stroke. 1998: 29: 399-403.
17. Kokubo Y, Choudhury AH, Date C, Yokoyama T, Hatiki S, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000: 31: 1299-1306.
18. Kussi T, Nieminen MS, Ehnholm C et al. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989: 9: 237-241.
19. Eichner JE, Kuller LH, Orchard TJ et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993: 71: 160-165.
20. Tiret L, de knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM, for the European Atherosclerosis research (EARS) Study Group. Apo E polymorphism and predisposition to coronary heart disease in youths of different European communities. Arterioscl Thromb 1994: 14: 1617-1624.
21. Pedro-Botet J, Senti M, Nogues X et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke; role of lipoprotein (a) trigltceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992: 23: 1556-1562.
22. Couderc R, Mahhieux F, Bailleu S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case control study. Stroke 1993: 24: 661-664.
23. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol 1996: 16: 1250-1255.
24. Henderson AS, Easteal S, Jorm AF et al. Apolipoprotein E allele E4, dementia and cognitive decline in a population sample. Lancet 1995: 346: 1387-1390.
25. Catto AJ, McCormack LJ, Mansfield MW et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000: 101: 399-404.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out for extracting DNA from human nucleated cells. Nucleic Acid Res 1988: 16: 1215-1220.
27. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991: 337: 1158-1159.
28. Srinivasan SR, Ehnholm SR, Elkasabany A, Berenson GS. Apolipoprotein E Polymorphism Modulates the association between obesity and dyslipidemia during young adulthood. The Bogalusa Heart Study. Metabolism 2001: 50: 696.
29. Chhabra S, Agarwal DP, Vsidht S et al. Study of apolipoprotein E polymorphism in normal healthy controls from Northern India. Dis Markers 2000: 16: 159-161.
30. Report of the joint committee for stroke facilities, I epidemiology for stroke facilities planning. Stroke 1972: 3: 359-371.
31. Kaul U, Sapra R, Ghose T. Dyslipidemia, in Indians: coronary artery disease in Indians. A global perspective. In: Sethi KK, ed. Monograph commemorating the golden jubilee of Cardiological Society of India. Mumbai, India: Stancare, Division of Ranboxy, India. 1998: 98-113.
32. Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (The Framingham experience). Am J Cardiol 1996: 77 (6): 6B-11B.
33. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS. Apolipoprotein E deficient mice have increased susceptibility to focal cerebral ischaemia. J Cereb Blood Flow Metab 1997: 17: 753-758.
34. Masliah E, Mallory M, Nianfeng G, Alford M, Vienbergs I, Roses AD. Neurodegeneration in the central nervous system of apo E deficient mice. Exp Neurol 1995: 136: 107-122.
35. Miyata M, Smith JD. Apolipoprotein E allele specific antioxidant activity and effects of cytotoxicity by oxidative insults and B amyloid peptides. Nat Genet 1996: 14: 55-61.
36. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. B amyloid mediated vasoactivity and vascular endothelial damage. Nature 1996: 380: 168-171.
37. Terry JG, Howard G, Mercuri M, Bond MG, Croue JRIII. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke 1996: 27: 1755-1759.